Hyperpolarized Gas MRI and High-Flow Oxygen Therapy for Chronic and Acute Lung Disease
This community investigates the diagnosis and management of chronic obstructive pulmonary disease, cystic fibrosis, and acute respiratory distress using advanced magnetic resonance imaging techniques and non-invasive oxygen delivery systems.
The research centers on the application of hyperpolarized gas magnetic resonance imaging, specifically utilizing dynamic nuclear polarization of xenon and helium, to visualize lung ventilation and perfusion in patients with COPD, asthma, and cystic fibrosis. A parallel strand of work focuses on the clinical efficacy of high-flow nasal cannula oxygen therapy for acute respiratory failure and distress syndrome. The literature includes randomized controlled trials comparing these interventions, functional lung assessments, and the development of imaging protocols for monitoring disease progression and treatment response in these specific pulmonary conditions.
The community is most heavily concentrated in oxygen research, representing 0.5% of all oxygen-related papers, and xenon research, where it accounts for 4.0% of the total output. It also contributes to helium research, comprising 0.9% of that element's tracked literature.
The group comprises 17,124 papers, with the highest publication volume appearing in Magnetic Resonance in Medicine, European Respiratory Journal, and Thorax.
Recent work includes updated GOLD guidelines for COPD management, studies on elexacaftor–tezacaftor–ivacaftor for cystic fibrosis, and trials evaluating targeted lung denervation and electrical impedance tomography for monitoring critically ill patients.